Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
European Journal of Internal Medicine|June 19, 2007
Defining the metabolic syndrome: Resolving unresolved issues?Jobien K Olijhoek, Yolanda van der Graaf, Steven M Haffner, et al.European Heart Journal|January 18, 2008
Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysmAnnemarie M J Wassink, Yolanda van der Graaf, Jobien K Olijhoek, et al.Journal of Vascular Surgery|January 11, 2007
The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial diseaseBertine M B Goessens, Yolanda van der Graaf, Jobien K Olijhoek, et al.American Heart Journal|September 26, 2007
Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular diseaseGideon R Hajer, Yolanda van der Graaf, Jobien K Olijhoek, et al.Heart (British Cardiac Society)|September 6, 2006
Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndromeGideon R Hajer, Yolanda van der Graaf, Jobien K Olijhoek, et al.Journal of Cardiovascular Pharmacology|August 2, 2008
The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trialJobien K Olijhoek, Gideon R Hajer, Yolanda van der Graaf, et al.Atherosclerosis|April 6, 2004
Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysmPetra M Gorter, Jobien K Olijhoek, Yolanda van der Graaf, et al.European Heart Journal|February 27, 2004
The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysmJobien K Olijhoek, Yolanda van der Graaf, Jan-Dirk Banga, et al.Atherosclerosis|March 22, 2007
Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial diseaseFabrice M A C Martens, Yolanda van der Graaf, Joke M Dijk, et al.Clinical Endocrinology|April 9, 2008
Lipid-lowering therapy does not affect the postprandial drop in high density lipoprotein-cholesterol (HDL-c) plasma levels in obese men with metabolic syndrome: a randomized double blind crossover trialGideon R Hajer, Geesje M Dallinga-Thie, Leonie C van Vark-van der Zee, et al.Pageof 2